-transparent.png){kind=logo}
We have successfully overcome severe neutropenia in an RA patient treated with gold salts, using granulocyte colony-stimulating factor (G-CSF), reducing the duration of neutropenia and risk of infection. The patient suffered no side effects, and use of G-CSF represents an important addition to the management of a life-threatening drug reaction.
Related Publications
D A Collins, and
J H Tobias, and
R P Hill, and
B E Bourke
January 1996,
Hematology (Amsterdam, Netherlands),
D A Collins, and
J H Tobias, and
R P Hill, and
B E Bourke
January 2020,
Revista da Associacao Medica Brasileira (1992),
D A Collins, and
J H Tobias, and
R P Hill, and
B E Bourke
December 2008,
The Journal of the Association of Physicians of India,
D A Collins, and
J H Tobias, and
R P Hill, and
B E Bourke
February 1995,
Nederlands tijdschrift voor geneeskunde,
D A Collins, and
J H Tobias, and
R P Hill, and
B E Bourke
February 1992,
Ugeskrift for laeger,
D A Collins, and
J H Tobias, and
R P Hill, and
B E Bourke
March 1995,
Nihon rinsho. Japanese journal of clinical medicine,
D A Collins, and
J H Tobias, and
R P Hill, and
B E Bourke
November 1999,
Nihon rinsho. Japanese journal of clinical medicine,
D A Collins, and
J H Tobias, and
R P Hill, and
B E Bourke
July 2010,
Nihon rinsho. Japanese journal of clinical medicine,
D A Collins, and
J H Tobias, and
R P Hill, and
B E Bourke
August 2005,
Nihon rinsho. Japanese journal of clinical medicine,
D A Collins, and
J H Tobias, and
R P Hill, and
B E Bourke
January 1992,
Medical and pediatric oncology,
